184 related articles for article (PubMed ID: 8890814)
1. Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. The Dutch Ibopamine Multicenter Trial Study Group.
Brouwer J; van Veldhuisen DJ; Man in 't Veld AJ; Haaksma J; Dijk WA; Visser KR; Boomsma F; Dunselman PH
J Am Coll Cardiol; 1996 Nov; 28(5):1183-9. PubMed ID: 8890814
[TBL] [Abstract][Full Text] [Related]
2. Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure.
Galinier M; Pathak A; Fourcade J; Androdias C; Curnier D; Varnous S; Boveda S; Massabuau P; Fauvel M; Senard JM; Bounhoure JP
Eur Heart J; 2000 Mar; 21(6):475-82. PubMed ID: 10681488
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of heart rate variability and ventricular arrhythmias during 13-year follow-up in patients with mild to moderate heart failure.
Smilde TD; van Veldhuisen DJ; van den Berg MP
Clin Res Cardiol; 2009 Apr; 98(4):233-9. PubMed ID: 19219394
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of heart rate variability during long-term follow-up in chronic haemodialysis patients with end-stage renal disease.
Hayano J; Takahashi H; Toriyama T; Mukai S; Okada A; Sakata S; Yamada A; Ohte N; Kawahara H
Nephrol Dial Transplant; 1999 Jun; 14(6):1480-8. PubMed ID: 10383012
[TBL] [Abstract][Full Text] [Related]
5. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients.
La Rovere MT; Pinna GD; Maestri R; Mortara A; Capomolla S; Febo O; Ferrari R; Franchini M; Gnemmi M; Opasich C; Riccardi PG; Traversi E; Cobelli F
Circulation; 2003 Feb; 107(4):565-70. PubMed ID: 12566367
[TBL] [Abstract][Full Text] [Related]
6. Complex heart rate variability and serum norepinephrine levels in patients with advanced heart failure.
Woo MA; Stevenson WG; Moser DK; Middlekauff HR
J Am Coll Cardiol; 1994 Mar; 23(3):565-9. PubMed ID: 8113535
[TBL] [Abstract][Full Text] [Related]
7. Prediction of sudden death in heart failure patients: a novel perspective from the assessment of the peak ectopy rate.
Casaleggio A; Maestri R; La Rovere MT; Rossi P; Pinna GD
Europace; 2007 Jun; 9(6):385-90. PubMed ID: 17437967
[TBL] [Abstract][Full Text] [Related]
8. Independent and incremental prognostic value of heart rate variability in patients with chronic heart failure.
Bonaduce D; Petretta M; Marciano F; Vicario ML; Apicella C; Rao MA; Nicolai E; Volpe M
Am Heart J; 1999 Aug; 138(2 Pt 1):273-84. PubMed ID: 10426839
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
[TBL] [Abstract][Full Text] [Related]
10. Synergistic prognostic implications of left ventricular mechanical dyssynchrony and impaired cardiac sympathetic nerve activity in heart failure patients with reduced left ventricular ejection fraction.
Doi T; Nakata T; Yuda S; Hashimoto A
Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):74-83. PubMed ID: 28158459
[TBL] [Abstract][Full Text] [Related]
11. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion.
Tamaki S; Yamada T; Okuyama Y; Morita T; Sanada S; Tsukamoto Y; Masuda M; Okuda K; Iwasaki Y; Yasui T; Hori M; Fukunami M
J Am Coll Cardiol; 2009 Feb; 53(5):426-35. PubMed ID: 19179201
[TBL] [Abstract][Full Text] [Related]
12. Six-minute walk test and heart rate variability: lack of association in advanced stages of heart failure.
Woo MA; Moser DK; Stevenson LW; Stevenson WG
Am J Crit Care; 1997 Sep; 6(5):348-54. PubMed ID: 9283671
[TBL] [Abstract][Full Text] [Related]
13. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Ponikowski P; Anker SD; Chua TP; Szelemej R; Piepoli M; Adamopoulos S; Webb-Peploe K; Harrington D; Banasiak W; Wrabec K; Coats AJ
Am J Cardiol; 1997 Jun; 79(12):1645-50. PubMed ID: 9202356
[TBL] [Abstract][Full Text] [Related]
14. Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. DIMT Study Group. Dutch Ibopamine Multicenter Trial.
van Veldhuisen DJ; Brouwer J; Man in 't Veld AJ; Dunselman PH; Boomsma F; Lie KI
Am J Cardiol; 1995 Apr; 75(12):796-800. PubMed ID: 7717282
[TBL] [Abstract][Full Text] [Related]
15. Fractal analysis and time- and frequency-domain measures of heart rate variability as predictors of mortality in patients with heart failure.
Mäkikallio TH; Huikuri HV; Hintze U; Videbaek J; Mitrani RD; Castellanos A; Myerburg RJ; Møller M;
Am J Cardiol; 2001 Jan; 87(2):178-82. PubMed ID: 11152835
[TBL] [Abstract][Full Text] [Related]
16. Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%.
Cygankiewicz I; Zareba W; Vazquez R; Bayes-Genis A; Pascual D; Macaya C; Almendral J; Fiol M; Bardaji A; Gonzalez-Juanatey JR; Nieto V; Valdes M; Cinca J; de Luna AB;
Am J Cardiol; 2009 Apr; 103(7):1003-10. PubMed ID: 19327431
[TBL] [Abstract][Full Text] [Related]
17. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study.
Copie X; Hnatkova K; Staunton A; Fei L; Camm AJ; Malik M
J Am Coll Cardiol; 1996 Feb; 27(2):270-6. PubMed ID: 8557893
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study.
Yamada T; Shimonagata T; Fukunami M; Kumagai K; Ogita H; Hirata A; Asai M; Makino N; Kioka H; Kusuoka H; Hori M; Hoki N
J Am Coll Cardiol; 2003 Jan; 41(2):231-8. PubMed ID: 12535815
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of exercise plasma noradrenaline levels for cardiac death in patients with mild heart failure.
Kinugawa T; Ogino K; Osaki S; Kato M; Igawa O; Hisatome I; Fujita M; Shigemasa C
Circ J; 2002 Mar; 66(3):261-6. PubMed ID: 11922275
[TBL] [Abstract][Full Text] [Related]
20. Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group.
Gradman A; Deedwania P; Cody R; Massie B; Packer M; Pitt B; Goldstein S
J Am Coll Cardiol; 1989 Sep; 14(3):564-70; discussion 571-2. PubMed ID: 2768707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
